PH19663A - Active compound combination of kitasamycin and quinoxaline di-n-oxides - Google Patents

Active compound combination of kitasamycin and quinoxaline di-n-oxides

Info

Publication number
PH19663A
PH19663A PH27778A PH27778A PH19663A PH 19663 A PH19663 A PH 19663A PH 27778 A PH27778 A PH 27778A PH 27778 A PH27778 A PH 27778A PH 19663 A PH19663 A PH 19663A
Authority
PH
Philippines
Prior art keywords
kitasamycin
oxides
active compound
compound combination
hydrogen
Prior art date
Application number
PH27778A
Inventor
Peter Henry Selle
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6140231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH19663(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PH19663A publication Critical patent/PH19663A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feed For Specific Animals (AREA)

Abstract

1. Active compound combination consisting of kitasamycin and 2-methyl-3-carboxamidoquinoxaline- -1,4-di-N-oxides of the general formula I see diagramm : EP0073390,P9,F2 wherein R**1 represents hydrogen, lower alkyl, lower alkoxy radicals and chlorine, R**2 represents hydrogen or a straight-chain or branched alkyl radical which is optionally substituted by a hydroxyl, lower alkoxy, carboalkoxy, mono- or dialkylamino radical, R**3 can represent hydrogen and wherein R**3 furthermore can be identical to or different from R**2 and in the case where R**2 is hydrogen R**3 can also represent the cyclohexyl radical and wherein in the case where R**2 and R**3 denote alkyl these radicals, together with the amide nitrogen atom, can be a constituent of a 5- or 6-membered heterocyclic ring system.
PH27778A 1981-08-27 1982-08-25 Active compound combination of kitasamycin and quinoxaline di-n-oxides PH19663A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813133888 DE3133888A1 (en) 1981-08-27 1981-08-27 ACTIVE COMBINATION OF KITASAMYCIN AND CHINOXALIN-DI-N-OXIDES

Publications (1)

Publication Number Publication Date
PH19663A true PH19663A (en) 1986-06-09

Family

ID=6140231

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27778A PH19663A (en) 1981-08-27 1982-08-25 Active compound combination of kitasamycin and quinoxaline di-n-oxides

Country Status (12)

Country Link
EP (1) EP0073390B1 (en)
JP (1) JPS5852224A (en)
KR (1) KR860000275B1 (en)
AT (1) ATE20171T1 (en)
AU (1) AU552563B2 (en)
BR (1) BR8205020A (en)
DE (2) DE3133888A1 (en)
EG (1) EG15924A (en)
ES (1) ES8400014A1 (en)
FI (1) FI70364C (en)
PH (1) PH19663A (en)
ZA (1) ZA826230B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230273A1 (en) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen LIGHT-STABILIZED CHINOXALINE DI-N-OXIDES
DE3340931A1 (en) * 1983-11-11 1985-05-23 Bayer Ag, 5090 Leverkusen DUST-FREE CHINOXALIN-1,4-DI-N-OXIDE
JPH06701B2 (en) * 1983-12-01 1994-01-05 旭化成工業株式会社 Veterinary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535309A (en) * 1967-09-01 1970-10-20 Kitasato Inst Antibiotics and their production
DE1670935C3 (en) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carboxamidoquinoxaline-1,4-dl-N-oxides, a process for their preparation and antibacterial agents containing these compounds
AT281841B (en) * 1968-10-03 1970-06-10 Bayer Ag PROCESS FOR THE PRODUCTION OF NEW 2-METHYL-3-CARBONIC ACIDAMIDO-QUINOXALINDI-N-OXIDEN- (1,4)
SU890961A3 (en) * 1976-01-20 1981-12-15 Циба-Гейги Аг (Фирма) Growth stimulating agent for animals
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides

Also Published As

Publication number Publication date
FI822950A0 (en) 1982-08-25
EP0073390A1 (en) 1983-03-09
ZA826230B (en) 1983-07-27
FI70364B (en) 1986-03-27
DE3133888A1 (en) 1983-03-10
ES515272A0 (en) 1983-10-16
ES8400014A1 (en) 1983-10-16
FI70364C (en) 1986-09-19
KR860000275B1 (en) 1986-03-26
AU8774882A (en) 1983-03-03
BR8205020A (en) 1983-06-07
ATE20171T1 (en) 1986-06-15
FI822950L (en) 1983-02-28
KR840000903A (en) 1984-03-26
EP0073390B1 (en) 1986-06-04
DE3271554D1 (en) 1986-07-10
EG15924A (en) 1986-12-30
AU552563B2 (en) 1986-06-05
JPS5852224A (en) 1983-03-28

Similar Documents

Publication Publication Date Title
NZ215008A (en) Heterocyclic compounds and herbicidal compositions
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
PL216409A1 (en)
ES476343A1 (en) Cyclopentan-1-amines
MY102277A (en) Quinoline compounds
ES430709A1 (en) 1-(Imidazolyl-1)-2-aryloxy-3-hydroxy-alkanes
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
EP0218541A3 (en) 3-vinyl and 3-ethinyl-beta-carboline derivatives, their preparation and their use as medicaments
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
MY102973A (en) Isoindolinyl alkyl piperazines
ES8401067A1 (en) Treatment of migraine with tropyl benzoate derivatives.
AU552563B2 (en) Active compound of kitasamycin and quinoxaline di-n- oxides
MX9505054A (en) Bisphenol ester derivatives.
ES453881A1 (en) 1,3-dithiolo(4,5-b)pyrazin-2-ylidene-propanedinitrile 4-oxide
AU567163B2 (en) B-carbolin-3-carboxylic acid derivatives
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
ES8401066A1 (en) 1,5-substituted isoquinoline derivatives.
ES466682A1 (en) Organic compounds
ES469896A1 (en) Hydroxythiazolidine-2-thiones
IE830246L (en) Carbacyclin derivatives.
ATE69819T1 (en) 1-OXA-1-DETHIA CEPHALOSPORIN COMPOUNDS AND ANTIBACTERIAL AGENT CONTAINING THEM.
GR851530B (en)
ES8300704A1 (en) Encainide N-oxide
DE3460030D1 (en) Alpha-alkoxylated n-(3,3,5- or 3,5,5-trimethylcyclohexen-1-yl)-n-alkyl or n-allyl-acetamides and their use in phytotoxic preparations